Equibles does not estimate personal net worth.
Get an email with a short summary when TriSalus Life Sciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get TLSI alertsTriSalus Life Sciences, Inc. reported in an 8-K filed April 29, 2026 that Richard Marshall was appointed Chief Medical Officer, effective June 29, 2026. TriSalus Life Sciences, Inc. reported in an 8-K filed April 7, 2026 that Richard Marshall was appointed Chief Medical Officer, effective June 29, 2026. Richard Marshall has spoken on 3 earnings calls across 1 company, most recently for TriSalus Life Sciences, Inc. on May 12, 2026. TriSalus Life Sciences, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at TriSalus Life Sciences, Inc. includes Mary Szela (CEO and Board Member), Karim Karti (Chairman), Mats Wahlström (Chairman and Board Member) and 7 others.
“As previously announced on April 7, 2026, the Company appointed Dr. Richard Marshall to Chief Medical Officer of the Company, effective June 29, 2026.”
“On April 1, 2026, TriSalus Life Sciences, Inc. (the “Company”) entered into an offer letter with Dr. Richard Marshall for the position of Chief Medical Officer.”
“I think the most interesting part about this data is that it's real world data. And this is from physicians who have been practicing. This is not a prospective study that's designed with tight parameters to ensure good data.”
“Those are cases that we're going to be able to add to our portfolio that weren't there in 2025.”
“I can comment a lot on it because I'm part of this. So as you may know, mapping procedures are performed prior to delivering Y-90 radiation into the liver, and it's very important to know exactly where that's going to go.”
Source not stated
Medical Devices · Healthcare
